5 results match your criteria: "Advocate Caldwell Breast Center[Affiliation]"
Cancer
August 2023
Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Background: There are no consensus guidelines for supplemental breast cancer screening with whole-breast ultrasound. However, criteria for women at high risk of mammography screening failures (interval invasive cancer or advanced cancer) have been identified. Mammography screening failure risk was evaluated among women undergoing supplemental ultrasound screening in clinical practice compared with women undergoing mammography alone.
View Article and Find Full Text PDFRadiology
May 2023
From the Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (E.F.C.); Sanford Health, Sioux Falls, SD (M.M.T.); Solis Mammography, Houston, Tex (C.R.P.); Sutter Health, Fremont, Calif (B.C.S.); Sutter Health, Palo Alto, Calif (S.Y.L.); Hologic, Marlborough, Mass (S.P., A.R.); OM1, Boston, Mass (Y.J., L.A.S.S., J.K.P.); and Department of Radiology, Advocate Caldwell Breast Center, Park Ridge, Ill (N.A.).
Background The use of digital breast tomosynthesis (DBT) is increasing over digital mammography (DM) following studies demonstrating lower recall rates (RRs) and higher cancer detection rates (CDRs). However, inconsistent interpretation of evidence on the risks and benefits of mammography has resulted in varying screening mammography recommendations. Purpose To evaluate screening outcomes among women in the United States who underwent routine DM or DBT mammographic screening.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 2021
Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Background: The coronavirus disease 2019 (COVID-19) pandemic led to a near-total cessation of mammography services in the United States in mid-March 2020. It is unclear if screening and diagnostic mammography volumes have recovered to prepandemic levels and whether use has varied by women's characteristics.
Methods: We collected data on 461 083 screening mammograms and 112 207 diagnostic mammograms conducted during January 2019 through July 2020 at 62 radiology facilities in the Breast Cancer Surveillance Consortium.
J Am Coll Radiol
July 2021
Division Chief, Breast Imaging Hospital of the University of Pennsylvania Vice Chair of Faculty Development, Department of Radiology, Perelman School of Medicine, Professor of Radiology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Purpose: Digital breast tomosynthesis (DBT) in conjunction with digital mammography (DM) is becoming the preferred imaging modality for breast cancer screening compared with DM alone, on the basis of improved recall rates (RR) and cancer detection rates (CDRs). The aim of this study was to investigate racial differences in the utilization and performance of screening modality.
Methods: Retrospective data from 63 US breast imaging facilities from 2015 to 2019 were reviewed.
Acad Radiol
May 2019
Department of Radiology, 3400 Spruce Street, Hospital of the University of Pennsylvania, Philadelphia, PA 19104. Electronic address:
Rationale And Objectives: To compare outcomes associated with breast cancer screening with digital mammography (DM) alone versus in combination with digital breast tomosynthesis (DBT) in a large representative cohort.
Materials And Methods: A total of 325,729 screening mammograms from 247,431 women were analyzed, across two healthcare systems, from June 2015 to September 2017. Patient level demographic, calculated risk levels, and clinical outcomes were extracted from radiology information system and electronic medical records.